The social cost of drugs: an estimation in France in 2019

This report presents a new estimate of the social cost of drugs in France in 2019, following a previous calculation in 2010

Coût social
See the notice on the bibliographic catalog

The results are not directly comparable, as several calculation parameters have been modified to take account of improvements in the statistical data available.

The social cost of drugs in France measures the monetary cost of the consequences of legal (alcohol and tobacco) and illegal drug use and trafficking during an average year of the decade.

It is made up of the external cost (value of human lives lost, loss of production) and the cost to public finances (prevention, repression and care, savings on pensions not paid out, and revenue from taxes levied on alcohol and tobacco). The calculation parameters follow the guidelines of the Quinet report.

Publication type
Briefing papers
Publication date
Language
Français
Anglais
Author(s)
KOPP
Pierre
Edited by
OFDT
Number of pages
15
ISBN
979-10-92728-75-0
Products & addictions
Alcohol
Cocaine and crack
Heroin and opioids
Tobacco
Themes
Public policy and healthcare provision
Territories
France

See also

30 years of penal response to driving under the influence of alcohol or drugs
  • Alcohol
  • Cannabis
  • Cocaine and crack
  • Heroin and opioids
  • MDMA/ecstasy and amphetamine
Tendances
161
2024
OFDT
8 pages
Drug use in adolescence: trends reported in 2022
  • Alcohol
  • Cannabis
  • e-Cigarette
  • Cocaine and crack
  • GHB and solvents
  • Heroin and opioids
  • Ketamine
  • LSD and mushrooms
  • MDMA/ecstasy and amphetamine
  • Poppers
  • Nitrous oxide
  • Tobacco
Briefing papers
2024
OFDT
17 pages
Psychoactive substances, users and markets in France in 2022
  • Benzodiazepines and gabapentinoids
  • Cannabis
  • Cocaine and crack
  • Heroin and opioids
  • Ketamine
  • LSD and mushrooms
  • MDMA/ecstasy and amphetamine
  • New Psychoactive Substances
  • Poppers
  • Nitrous oxide
  • Others
Tendances
160
2023
OFDT
8 pages

latest publications Briefing papers

All publications Briefing papers
Drug use in adolescence: trends reported in 2022
  • Alcohol
  • Cannabis
  • e-Cigarette
  • Cocaine and crack
  • GHB and solvents
  • Heroin and opioids
  • Ketamine
  • LSD and mushrooms
  • MDMA/ecstasy and amphetamine
  • Poppers
  • Nitrous oxide
  • Tobacco
  • Users
  • France

Psychoactive substance use among middle school and high school students: results of the EnCLASS 2022 survey.

Briefing papers
2024
OFDT
17 pages
Alcohol consumption and its consequences in France in 2022
  • Alcohol
  • Supply and markets
  • Treatment
  • Users
  • France

This report from the French Monitoring Centre for Drugs and Drug Addiction (OFDT) provides an overview of the supply, uses, and the social and health consequences of alcohol consumption in France in 2022

Briefing papers
2023
OFDT
9 pages
Opioid substitution treatment in France: 2023 report
  • Heroin and opioids
  • Treatment
  • France

The aim of this report is to present updated data on opioid substitution treatment in France. It is based on the latest available data, the year of which may vary from 2019 to 2022 depending on the source and the treatment period.

Briefing papers
2023
OFDT
14 pages
Statistics on people receiving care in specialised drug treatment centres in 2020
  • Alcohol
  • Benzodiazepines and gabapentinoids
  • Cannabis
  • Cocaine and crack
  • GHB and solvents
  • Heroin and opioids
  • Gambling
  • Ketamine
  • LSD and mushrooms
  • MDMA/ecstasy and amphetamine
  • Tobacco
  • Others
  • Treatment
  • France

This report of the RECAP survey (common data collection on addictions and treatments) reviews the main recent changes in the statistics on people with addictive behaviour problems accompanied and cared for by teams from specialised drug treatment centres (CSAPA in French). 

Briefing papers
2023
OFDT
16 pages